Reposted by @aliciamconway.bsky.social
AMMF welcomes NICE’s recommendation that a new life-extending targeted treatment for HER2-positive biliary tract cancers, zanidatamab, should be used by the NHS.
Read more at ammf.org.uk/2026/04/21/zanidatamab-…